To date, Italy is to be considered a “non-endemic area for Zika virus as no locally transmitted cases of infection (autochthonous), but only imported cases (travellers from areas where the virus is circulating), have been recorded. The Italian National Blood Centre (CNS) confirms the validity of the measures for the prevention of transfusion transmission of Zika virus infection already adopted in Italy. These are based on strengthening donor anamnestic surveillance (with particular reference to travel), and applying the criterion of the temporary suspension of donors who have stayed in areas considered at risk following reported autochthonous cases of Zika virus infection.
21 September, 2023
In the Italian transfusion system, self-sufficiency of labile blood components (red blood cells, platelets and plasma) and plasma-derived products is ensured by voluntary, periodic, responsible and unpaid donation. Self-sufficiency is…
12 September, 2023
In order to ensure an ethical and rational use of national plasma, Italy exports plasma-derived medicinal products (PDMPs) in excess of national requirements within the framework of specific international cooperation…
28 February, 2023